Navana Pharmaceuticals is set to establish an herbal division at its factory premises, pending regulatory approval, the company disclosed on the Dhaka Stock Exchange (DSE) website.

The proposed herbal division will cover approximately 10,000 square feet and require an estimated investment of Tk 20.85 crore. Funding will come from a combination of internal resources and external financing.

The company aims to complete the project within five years, projecting Tk 40 crore in additional revenue during its first year of operation.

The decision to proceed with the new division was finalized during a board meeting on January 15, 2025.

Shares of Navana Pharmaceuticals increased by 2.88% to Tk 46.5 during mid-day trading today, reflecting investor optimism.

Established in 1992, Navana Pharmaceuticals operates two primary divisions: veterinary division and human health division.